BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $111,000 | -50.0% | 105,000 | -51.8% | 0.00% | 0.0% |
| Q1 2018 | $222,000 | -35.8% | 218,000 | -31.9% | 0.00% | -50.0% |
| Q4 2017 | $346,000 | -3.9% | 320,000 | -0.9% | 0.00% | 0.0% |
| Q3 2017 | $360,000 | +0.6% | 323,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $358,000 | +2.3% | 323,000 | +4.2% | 0.00% | 0.0% |
| Q1 2017 | $350,000 | +17.4% | 310,000 | +16.1% | 0.00% | 0.0% |
| Q4 2016 | $298,000 | +20.2% | 267,000 | +29.0% | 0.00% | 0.0% |
| Q3 2016 | $248,000 | 0.0% | 207,000 | -7.6% | 0.00% | 0.0% |
| Q2 2016 | $248,000 | +8.3% | 224,000 | +13.1% | 0.00% | +100.0% |
| Q1 2016 | $229,000 | +13.4% | 198,000 | +25.3% | 0.00% | 0.0% |
| Q4 2015 | $202,000 | +1.0% | 158,000 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $200,000 | -27.8% | 155,000 | -13.9% | 0.00% | -50.0% |
| Q2 2015 | $277,000 | -43.6% | 180,000 | -45.5% | 0.00% | -33.3% |
| Q1 2015 | $491,000 | -18.7% | 330,000 | -35.9% | 0.00% | -25.0% |
| Q4 2014 | $604,000 | -29.6% | 515,000 | -36.6% | 0.00% | -33.3% |
| Q3 2014 | $858,000 | -24.7% | 812,000 | -26.4% | 0.01% | -25.0% |
| Q2 2014 | $1,140,000 | +115.1% | 1,103,000 | +127.4% | 0.01% | +300.0% |
| Q1 2014 | $530,000 | +8.8% | 485,000 | +5.2% | 0.00% | 0.0% |
| Q4 2013 | $487,000 | – | 461,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 6,000,000 | $6,271,000 | 4.60% |
| Weiss Asset Management LP | 27,058,000 | $28,040,000 | 2.16% |
| Birch Grove Capital LP | 4,643,000 | $4,802,000 | 1.91% |
| CSS LLC/IL | 20,256,000 | $20,993,000 | 0.89% |
| PIPER SANDLER & CO. | 1,000,000 | $1,036,000 | 0.86% |
| AQR Arbitrage LLC | 24,825,000 | $25,686,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,000,000 | $17,589,000 | 0.20% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,182,000,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,107,000 | $4,256,000 | 0.12% |
| Verition Fund Management LLC | 3,106,000 | $3,214,000 | 0.12% |